The 51 contraceptive products, including the controversial Implanon and Implanon NXT, that were covered by the temporary restraining order (TRO) of the Supreme Court, have been determined to be non-abortifacient, or cannot cause abortion, by the Food and Drug Administration (FDA).
In Advisory No. 2017-302 dated Nov. 11, 2017, the FDA said it has already concluded the re-evaluation of the 51 contraceptive products.
“Per the FDA Resolutions dated 10 November 2017 (on the applications for recertification filed by the Market Authorization Holders [MAHs] with opposition filed by Alliance for the Family Foundation, Philippines, Inc. [ALFI]), the foregoing contraceptive products have been determined to be NON-ABORTIFACIENT,” the FDA said in its advisory.
